WuXi Biologics
2025.06.16
16:10
Hong Kong stocks closed: Hang Seng Index rose 0.70% Hang Seng Technology Index rose 1.15%
At the close of Hong Kong stocks, the Hang Seng Index rose 0.70%, and the Hang Seng Technology Index rose 1.15%. The Hong Kong Stock Technology ETF (159751) closed up 0.78%, and the Hang Seng Hong Kong Stock Connect ETF (159318) closed up 0.77%. Shandong Molong rose more than 30%, ZhongAn Online rose more than 12%, and Xiaomi Group rose more than 4%; WuXi Biologics fell more than 5%.
12:01
Hong Kong Stocks Midday Review: Hang Seng Index fell 0.12% Hang Seng Technology Index rose 0.15%
At the close of Hong Kong stocks at noon, the Hang Seng Index fell 0.12%, and the Hang Seng Technology Index rose 0.15%. Oil and gas stocks and domestic real estate stocks led the gains, with Shandong Molong rising more than 30%, ZhongAn Online and R&F Properties rising nearly 10%, and WuXi Biologics falling more than 6%.
09:23
Hong Kong stocks opened, the Hang Seng Index opened down 0.42%, the Sci-Tech Index opened down 0.61%. WuXi Biologics (02269.HK) fell 3.57% as the company's major shareholder placed existing shares.
07:35
WuXi Biologics: Major shareholder places existing shares
WuXi Biologics announced on the Hong Kong Stock Exchange that on June 14, the company's board of directors was informed by one of the company's major shareholders that it had entered into a block transaction agreement with Morgan Stanley International plc, pursuant to which the placing agent has agreed to place 82.94 million existing shares of the company held by Biologics Holdings (equivalent to approximately 2.04% of the total issued share capital of the Company as of the date of this announcement) to parties independent of and not related to the Company at a price of HK$26.6 per share.
2025.06.12
09:55
Hong Kong-listed biopharmaceutical stocks rose in early trading, with Zai Lab (09688.HK) up more than 8.5%, Kelun Biotech (06990.HK) up nearly 6%, BeiGene (06160.HK) up more than 4%, Rongchang Biopharmaceuticals (09995.HK), WuXi Biologics (02269.HK), InnoCare Pharma (09969.HK), and WuXi AppTec (02359.HK) all up more than 3%.
2025.06.10
09:46
Hong Kong-listed pharmaceutical stocks fluctuated upward; Tigermed rose more than 7%
Hong Kong-listed pharmaceutical stocks fluctuated upward, with Tiger Pharmaceuticals rising more than 7%, CStone Pharmaceuticals and Corning Life Sciences both rising nearly 6%, Zhaoyan Pharmaceutical rising more than 5.5%, and WuXi Biologics rising more than 4%.
2025.06.09
10:07
Hong Kong-listed biopharmaceutical stocks fluctuated and rose during the session; GenScript Biopharma rose more than 10%
Hong Kong-listed biopharmaceutical stocks fluctuated upward during intraday trading, with GeneScript Biopharma rising more than 10%, InnoCare Pharma rising more than 9%, Tiger Pharmaceuticals rising more than 6%, Junshi Biosciences rising more than 5%, and WuXi Biologics rising more than 4%.
2025.05.29
10:42
Hong Kong stocks' innovative drug concept strengthened; WuXi Biologics rose more than 8%
The concept of innovative drugs in Hong Kong stocks strengthened, with WuXi Biologics rising by more than 8%, followed by CStone Pharmaceuticals, Corning Life Sciences, Tigermed, Zhaoyan Pharmaceuticals, Fosun Pharma and others.
09:58
The Hong Kong stock market's biotechnology sector rose, with Innovent Biologics (02126.HK) up 11.7%, WuXi Biopharmaceuticals (02268.HK) up 7.34%, WuXi Biologics (02269.HK) up 6.85%, and Junshi Biosciences (01877.HK) up nearly 6%.
2025.05.27
09:56
Hong Kong-listed pharmaceutical stocks rose, with Agilent Technologies rising more than 7%.
Hong Kong-listed pharmaceutical stocks rose, with CStone Pharmaceuticals rising more than 7%, followed by Corning Life Sciences, WuXi Biologics, WuXi AppTec, and Zhaoyan Pharmaceutical.
09:42
The Hong Kong stock market's biopharmaceutical sector strengthened, with Zai Lab (09688.HK) rising nearly 3%, WuXi Biologics (02269.HK) rising nearly 2%, and WuXi AppTec (02359.HK), Rongchang Biopharma (09995.HK) and others following suit.
2025.05.21
09:59
Hong Kong-listed pharmaceutical stocks rose, with Agilent Technologies up nearly 9%
Hong Kong-listed pharmaceutical stocks rose, with CStone Pharmaceuticals rising nearly 9%, followed by Kangfang Biopharma, 3SBio, WuXi Biologics, CSPC Pharmaceutical Group, and WuXi AppTec.
2025.05.13
09:23
Hong Kong stocks' innovative drug sector rebounded, with BeiGene rising nearly 7%
The Hong Kong stock market's innovative drug sector rebounded, with BeiGene rising nearly 7%, Rongchang Biopharma and Innovent Biologics rising more than 4%, and Shijiazhuang Pharmaceutical Group, Corning Life Sciences, and WuXi Biologics rising more than 1%.
2025.05.07
16:10
At the close of Hong Kong stocks, the Hang Seng Index closed up 0.13%, while the Tech Index closed down 0.75%; China Resources Land Development (00881.HK) rose nearly 5%, AIA Group (01299.HK) rose nearly 3%, WuXi Biologics (02269.HK) fell nearly 6.7%, while Mengniu Dairy (02319.HK) and China Biologic Products (01177.HK) both fell more than 3%.
09:44
Hong Kong stocks' innovative drug sector fell in early trading, with BeiGene falling more than 6%
The Hong Kong stock market's innovative drug sector fell in early trading, with BeiGene falling more than 6%, Rongchang Biopharma falling more than 5%, Innovent Biologics, WuXi Biologics, and Junshi Biosciences all falling.
Load More
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
Weekly Highlights
Air India flight returns after takeoff due to technical issues

2025-06-16

Southbound funds made a large net purchase of 5.743 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), China Construction Bank and Meituan-W received net purchases of HK$1.108 billion and HK$493 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$1.489 billion; in terms of Hong Kong Stock Connect (Shenzhen), Meituan-W and Kangfang Biopharma received net purchases of HK$622 million and HK$206 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$391 million.

2025-06-16

Arm (ARM.O): We are better than Nvidia on a wider range of platforms.

2025-06-12

Espressif: Wi-Fi 7 and AI computing chips will be launched in the next two to three years

2025-06-19

JD.com: Stablecoin is being tested in the Hong Kong Monetary Authority and is expected to be launched in the fourth quarter of this year

2025-06-19

ASIA TECH WIRE

Grasp technology trends

Download